The p53 protein is a multifunctional transcription factor which orches
trates cellular responses to DNA damage, so helping to conserve genomi
c stability. It may also regulate genes involved in intercellular sign
alling, such as thrombospondin, a negative regulator of angiogenesis a
nd metastatic spread. Activation of p53 target genes requires sequence
-specific DNA binding, a function which maps to the central core of th
e protein. Missense point mutations within this domain inactivate p53
tumour suppressor function and involve either (i) DNA contact residues
, or (ii) residues important for conformational structure. Using in vi
tro techniques we have analysed seven DNA contact mutants and 17 struc
tural mutants known to occur in cancer. We show that DNA contact mutan
ts can be carried into specific DNA interaction when co-expressed with
wild type protein. For structural mutants, 9/17 retained DNA binding
capacity and, with one exception, DNA binding correlated with conforma
tional flexibility of the mutant protein. The exception was Asp(281),
which appeared essential for DNA interaction, probably due to its abil
ity to form salt bridges with DNA contact residues Arg(273) and Arg(28
0). We suggest that different classes of p53 mutant may prove amenable
to different strategies for restoration of wild type tumour suppresso
r function as means of anti-cancer therapy.